Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.51B |
| Enterprise Value | 2.37B |
| P/E Ratio | -6.79 |
| PEG Ratio | 4.72 |
| Price/Sales Ratio | 3.83 |
| Price/Book Ratio | 0.63 |
| Enterprise/Revenue | 1.83 |
| Enterprise/EBITDA | -4.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.53 |
| Operating Margin | -0.51 |
AD
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | -0.09 |
Income Statement
| Revenue | 947.38M |
| Revenue/Share | 5.34 |
| Gross Profit | 958.99M |
| EBITDA | -397.87M |
| Net Income | -573.6M |
| Diluted EPS | -2.93 |
Balance Sheet
| Total Cash | 2.4B |
| Total Cash/Share | 12.53 |
| Total Debt | 204.66M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 3.79 |
| Book Value Per Share | 31.25 |
Price History
| 52-Week Change | -34.75 |
| 52-Week High | 30 |
| 52-Week Low | 17.03 |
| Moving Average 50 Days | 19.11 |
| Moving Average 200 Days | 22.61 |
Statistics
| Average Volume | 1.6M |
| Shares Outstanding | 201.6M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 6:5 |
| Last Split Date | June 26, 2023 |
AD
